Should we vaccinate people against Lyme like we do dogs? | Study of wild chimpanzee diet might lead to treatments for people | Experimental drug inhibits coronaviruses in mice
July 5, 2017
FBR Smartbrief
Top Story
Should we vaccinate people against Lyme like we do dogs?
Should we vaccinate people against Lyme like we do dogs?
(Getty Images/Getty Images)
A Lyme disease vaccine developed for humans with contributions from rheumatologist Allen Steere in the late 1990s showed 80% efficacy, but it was taken off the market after some consumers complained about side effects, though no scientific evidence linking patient symptoms to the vaccine was found. Dogs are often vaccinated against the disease, and Steere says it is time to rethink the availability of the vaccine for humans.
PBS (6/28) 
LinkedIn Twitter Facebook Google+ Email
Research Breakthroughs
Study of wild chimpanzee diet might lead to treatments for people
Study of wild chimpanzee diet might lead to treatments for people
(Johan Ordonez/AFP/Getty Images)
Botanist Constant Ahoua is studying food eaten by wild chimpanzees in Cote d'Ivoire to identify compounds with potentially medicinal properties, and he and his colleagues have found seven compounds that appear to inhibit enzymes associated with cancer as well as others that have antibacterial and antifungal properties. Elephants, wild boar, cats and dogs are among the animals that turn to vegetation for healing, and studying the ways in which they do so has long shed light on medicinal plants.
Quartz (7/4) 
LinkedIn Twitter Facebook Google+ Email
Experimental drug inhibits coronaviruses in mice
Experimental drug inhibits coronaviruses in mice
(Christian Keenan/Getty Images)
An experimental drug was effective in mice against coronaviruses including severe acute respiratory syndrome and Middle East respiratory syndrome, researchers report in Science Translational Medicine, and the drug is also being tested against Ebola virus. Researchers will continue to use the compound "as a probe to try to understand the biology of the virus, how and why this drug works, and to identify new targets for inhibiting coronaviruses," said Vanderbilt University professor Mark Denison.
HealthDay News (6/29) 
LinkedIn Twitter Facebook Google+ Email
Wis. lab holds 56,000 animal eyeballs and counting
At the University of Wisconsin at Madison's Comparative Ocular Pathology Laboratory, researchers have amassed more than 56,000 animal-eye specimens to aid in animal-vision research, many submitted by veterinarians seeking assistance with diagnoses, but the team is always looking for more. One current project includes studying the effect of the Zika virus on developing eyes, said lab director Leandro Teixeira.
National Public Radio (7/2) 
LinkedIn Twitter Facebook Google+ Email
Ultrafast scanning tech takes researchers inside roundworm organelles
A new technique known as ultrafast scanning fluorescence correlation spectroscopy has given researchers a new window into the inner workings of membraneless organelles taken from roundworms, finding a surprisingly sparse, flaccid structure. The findings lay the groundwork for exploring regulatory mechanisms, and if successful, "the impact could be transformative: It's not just cancer, it's neurodegeneration, about developmental disorders, and even the fundamentals of cell biology," said researcher Rohit Pappu.
Futurity (7/3) 
LinkedIn Twitter Facebook Google+ Email
Organoids could lead to new drug development methods
Scientists are seeking permission to grow organoids derived from the cells of all 1,500 people in the Netherlands who have cystic fibrosis so they assess treatment efficacy, allowing doctors to give drugs only to people whose disease is likely to respond. The model could be used to test other drugs for diseases caused by specific genetic mutations.
MIT Technology Review online (free registration) (6/29) 
LinkedIn Twitter Facebook Google+ Email
Other News
Animal Health
Canine arthritis treatment options expand
University of Pennsylvania veterinarian Kimberly Agnello recommends owners manage canine arthritis pain by keeping pets at a healthy weight, but rehabilitative exercise and nonsteroidal anti-inflammatory drugs including the recently approved grapiprant are also important tools for managing pain, writes veterinarian Sarah Wooten. Agnello sees translational medicine as a promising source of arthritis treatments for animals and humans, with ongoing research exploring procedures that resurface cartilage, partial-joint replacements, ligament transplant, treatment to improve cartilage blood supply and a pain-relief compound known as resiniferatoxin.
The Bark online (6/28) 
LinkedIn Twitter Facebook Google+ Email
Fla. researchers find rat lungworm in 5 counties
Fla. researchers find rat lungworm in 5 counties
(Sean Gallup/Getty Images)
Researchers from the University of Florida College of Veterinary Medicine have found the rat lungworm parasite in five Florida counties, according to a paper published in PLOS ONE, and parasitologist Heather Walden says people should take precautions including diligent washing of produce. The parasite can cause meningitis in humans and animals, and it is spread by rats and snails.
The Gainesville Sun (Fla.) (6/28) 
LinkedIn Twitter Facebook Google+ Email
FBR News
Donate to FBR
For 35 years, FBR has advanced biomedical research for the sake of both human and animal health. We can't do our job without your support. Please give what you can. Together we will continue to make a difference.
LinkedIn Twitter Facebook Google+ Email
You manage things; you lead people.
Grace Hopper,
computer scientist and naval officer
LinkedIn Twitter Facebook Google+ Email
Learn more about FBR:
About FBR | Donate
About FBR
The Foundation for Biomedical Research (FBR) is the nation’s oldest and largest non-profit dedicated to improving human and animal health by promoting public understanding and support for biomedical research. Our mission is to educate people about the essential role animal research plays in the quest for medical advancements, treatments and cures for both people and animals.
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information